82 related articles for article (PubMed ID: 476707)
1. Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy.
Falkson HC; van der Watt JJ; Portugal MA; Schoeman HS; Falkson G
Cancer Treat Rep; 1979 Aug; 63(8):1303-9. PubMed ID: 476707
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte alkaline phosphatase and carcinoembryonic antigen in breast cancer patients. Influence of the treatment on the markers.
Walach N; Guterman A; Zaidman JL; Scharf S; Weinberger L; Kaufman S
Neoplasma; 1990; 37(6):627-30. PubMed ID: 2274082
[TBL] [Abstract][Full Text] [Related]
3. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
[TBL] [Abstract][Full Text] [Related]
4. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.
Tondini C; Hayes DF; Gelman R; Henderson IC; Kufe DW
Cancer Res; 1988 Jul; 48(14):4107-12. PubMed ID: 3164256
[TBL] [Abstract][Full Text] [Related]
5. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer].
Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA
Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapy.
Falkson HC; Falkson G; Portugal MA; van der Watt JJ; Schoeman HS
Cancer; 1982 May; 49(9):1859-65. PubMed ID: 7074585
[TBL] [Abstract][Full Text] [Related]
7. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)].
Pompecki R; Schröder G; Garbrecht M; Frahm H
Dtsch Med Wochenschr; 1978 Apr; 103(14):620-2. PubMed ID: 639696
[TBL] [Abstract][Full Text] [Related]
8. Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer.
Ahlemann LM; Staab HJ; Anderer FA
Biomedicine; 1980 Dec; 32(4):194-9. PubMed ID: 7470582
[TBL] [Abstract][Full Text] [Related]
9. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
Staab HJ; Ahlemann LM; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
[TBL] [Abstract][Full Text] [Related]
10. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
[TBL] [Abstract][Full Text] [Related]
12. Three-year follow-up of carcinoembryonal antigen levels in the serum of patients with breast cancer.
Lang BA; Kocent A; Nekulová M; Hlávková J
Neoplasma; 1984; 31(1):79-87. PubMed ID: 6700798
[TBL] [Abstract][Full Text] [Related]
13. Postoperative borderline elevated CEA predicts for earlier relapse in patients with rectal cancer receiving adjuvant postoperative therapy.
Dawson LA; Franssen E; Davey P
Cancer J Sci Am; 1999; 5(6):374-9. PubMed ID: 10606480
[TBL] [Abstract][Full Text] [Related]
14. Transient carcinoembryonic antigen elevations during adjuvant chemotherapy for colorectal cancer reflect the burden of residual micrometastatic disease.
Yau T; Wong H; Chan P; Chan T; Mak J; Epstein RJ
Clin Colorectal Cancer; 2010 Apr; 9(2):108-12. PubMed ID: 20378505
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen (CEA) measurements as an aid to management of patients with lung cancer treated by radiotherapy.
Ahlemann LM; Staab HJ; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):143-50. PubMed ID: 7279701
[TBL] [Abstract][Full Text] [Related]
17. Correlation of single and serial CEA determinations with the clinical evolution of cancer patients.
de Levin RW; Levin E
Arch Geschwulstforsch; 1982; 52(2):105-12. PubMed ID: 7103688
[TBL] [Abstract][Full Text] [Related]
18. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
Guadagni F; Ferroni P; Carlini S; Mariotti S; Spila A; Aloe S; D'Alessandro R; Carone MD; Cicchetti A; Ricciotti A; Venturo I; Perri P; Di Filippo F; Cognetti F; Botti C; Roselli M
Clin Cancer Res; 2001 Aug; 7(8):2357-62. PubMed ID: 11489813
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen in patients with colorectal cancer: correlation between stage of disease and antigen level.
Bartal AH; Ayalon D; Cordova T; Avidan S; Robinson E
Isr J Med Sci; 1983 Sep; 19(9):801-5. PubMed ID: 6643017
[TBL] [Abstract][Full Text] [Related]
20. Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer.
Mughal AW; Hortobagyi GN; Fritsche HA; Buzdar AU; Yap HY; Blumenschein GR
JAMA; 1983 Apr; 249(14):1881-6. PubMed ID: 6834584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]